Anti-DRG1 antibodies are used in the immunodetection of the protein developmentally regulated GTP binding protein 1. In humans, the canonical protein has a reported length of 367 amino acid residues and a mass of 40.5 kDa. Its subcellular localization is in the nucleus and cytoplasm. It is notably expressed in skeletal muscle, heart, and kidney. A member of the OBG GTPase protein family, DRG1 is known to catalyze the conversion of GTP to GDP through hydrolysis of the gamma-phosphate bond in GTP. Synonyms for this target antigen include NEDD-3, TRAFAC GTPase DRG1, neural precursor cell expressed developmentally down-regulated protein 3, neural precursor cell expressed, developmentally down-regulated 3, and NEDD3. DRG1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some DRG1 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.